Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tubivac (V7) in Tuberculosis
NCT01977768Phase 3Completed
- Sponsor
- Immunitor Inc.
- Start
- Mar 2014
- Primary completion
- Oct 2018
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of mycobacterium vaccae in Tuberculosis (TB), sponsored by Immunitor Inc.. Started Mar 2014; status: completed.
02
Drugs
mycobacterium vaccae
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01977768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977768.